CFO transition
MSC Industrial Direct Co., Inc. CFO transition: Robert Kuhns to succeed Greg Clark
MSC Industrial Direct Co., Inc. reported in a Form 8-K filed September 8, 2026 that Robert Kuhns will succeed Greg Clark as Executive Vice President and Chief Financial Officer, effective September 14, 2026.
In the filing's words
effective September 14, 2026, Robert Kuhns has been appointed as the Executive Vice President and Chief Financial Officer of the Company.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | MSC Industrial Direct Co., Inc. (MSM) |
|---|---|
| Event | Transition |
| Incoming | Robert Kuhns |
| Outgoing | Greg Clark |
| Title in the filing | Executive Vice President and Chief Financial Officer |
| Effective | September 14, 2026 |
| 8-K filed | September 8, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Vice President and Chief Financial Officer, TopBuild Corp. |
| SEC CIK | 0001003078 |
MSC Industrial Direct Co., Inc. reported this change in a Form 8-K, Item 5.02, filed September 8, 2026. The filing's own words are quoted above.
Other records naming Robert Kuhns
1The incoming officer on this record, matched by name. Career line.
2026-10-22 · 10-K signature
Robert Kuhns signed MSC Industrial Direct Co., Inc.'s annual report as Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Robert Kuhns? Send a correction with the primary source.